In focus · trending topic

immunotherapy

127 stories · following the connections

Webinar to Reveal Data Supporting the Use of MuScreen™ for Preclinical Immunotherapeutic Development

By Nasdaq OMXFeb 27, 2018, 1:01 PM UTC

Tempus Launches Tempus xE, Whole Exome Sequencing to Empower Data-Driven Cancer Care and Research

By Nasdaq OMXFeb 22, 2018, 3:30 PM UTC

Enhanced MuScreen™ Platform Revolutionizes Preclinical Development of Immunotherapeutics

By Nasdaq OMXFeb 9, 2018, 1:00 PM UTC

Mr. David Ben Naim, CPA, MBA Joins Todos Medical as Chief Financial Officer

By Nasdaq OMXFeb 6, 2018, 1:00 PM UTC

Poseida Therapeutics Appoints Martin Giedlin, Ph.D., as Vice President, Technical Operations

By Nasdaq OMXFeb 5, 2018, 1:01 PM UTC

Galectin Therapeutics Granted Patents in China and Japan that Support NASH and Cancer Immunotherapy Clinical Development Programs

By Nasdaq OMXJan 25, 2018, 1:31 PM UTC

Data on Novel Humanized Models for Targeted Immunotherapy Development, a CrownBio Conference Talk on January 24th, 2018

By Nasdaq OMXJan 23, 2018, 1:40 PM UTC

INmune Bio presenting at NobleCon14 on January 29th

By Nasdaq OMXJan 23, 2018, 1:31 PM UTC